Next Article in Journal
LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression
Previous Article in Journal
Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors
 
 
Correction to Cells 2022, 11(3), 364.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Lee et al. Protein Arginine Methyltransferases in Neuromuscular Function and Diseases. Cells 2022, 11, 364

1
Research Institute for Aging-Related Diseases, AniMusCure Inc., Suwon 16419, Korea
2
Department of Molecular Cell Biology, School of Medicine, Sungkyunkwan University, Suwon 16419, Korea
3
Single Cell Network Research Center, Sungkyunkwan University, Suwon 16419, Korea
*
Authors to whom correspondence should be addressed.
Submission received: 20 July 2022 / Accepted: 22 July 2022 / Published: 22 August 2022
The authors wish to make the following corrections to this paper [1]:
For Table 1, reference [1] has been changed to [64]; reference [2] has been changed to [72]; reference [3] has been changed to [73]; reference [4] has been changed to [82]; reference [5] has been changed to [123]; reference [6] has been changed to [83]; reference [7] has been changed to [92]; reference [8] has been changed to [95]; reference [9] has been changed to [98]. The corrected Table 1 showed as below:
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.

Reference

  1. Lee, J.; An, S.; Lee, S.-J.; Kang, J.-S. Protein Arginine Methyltransferases in Neuromuscular Function and Diseases. Cells 2022, 11, 364. [Google Scholar] [CrossRef] [PubMed]
Table 1. Effect of targeting PRMTs on NMD phenotypes.
Table 1. Effect of targeting PRMTs on NMD phenotypes.
PRMTMethodModelEffect on NMD Phenotype
General methyltransferase inhibitorAdOxHela cellsRescues nuclear import of FUS mutants (R524S, R522G, R525L) [64]
General methyltransferase inhibitorAdOxPrimary rat hippocampal neuronsRescues nuclear import of FUS mutant (P525L) [64]
General methyltransferase inhibitorAdOxPrimary motor neuronsDiminishes cytoplasmic FUS mutants (R521H, R521G, R521C) [72]
General methyltransferase inhibitorAdOxALS patient-derived lymphoblastoid cellsRescues nuclear import of FUS mutant (R518G) [73]
PRMT1siRNA KDHela cellsPartial rescue of nuclear import of FUS mutant (P525L) [64]
PRMT1KOMEFDiminishes cytoplasmic FUS mutants (R521H, R521G, R521C) [72]
PRMT1siRNA KDHEK293Diminishes cytoplasmic FUS mutants (R521H, R521G, R521C) [72]
PRMT1siRNA KDPrimary motor neuronsIncreases cytoplasmic FUS mutants (R521H, R521G, R521C) [72]
PRMT1Inhibitor (AMI-1)ALS patient-derived lymphoblastoid cellsRescues nuclear import of FUS mutant (R518G) [73]
PRMT1shRNA KDCortical neuronsEnhances neurite shortening by FUS-R521C under oxidative stress [82]
PRMT1OverexpressionCortical neuronsPrevents neurite shortening by FUS-R521C under oxidative stress [82]
PRMT1Inhibitor (MS023)NSC-34Abrogates PR15-induced toxicity [123]
DART1
(PRMT1/PRMT8 ortholog)
siRNA KDDrosophilaEnhances neurodegeneration of eyes induced by wild-type FUS or FUS-R521H [73]
DART1
(PRMT1/PRMT8 ortholog)
siRNA KDDrosophilaEnhances neurodegeneration of eyes induced by wild-type FUS or FUS-P525L [83]
PRMT5Inhibitor (CMP5 or HLCL65)Mouse memory T cellsSuppresses memory T cell expansion [92]
PRMT5Inhibitor (CMP5) or shRNA KDHuman memory T cellsSuppresses memory T cell activation and expansion, partly through downregulation of IL-2 [92]
PRMT5Inhibitor (CMP5)OVA-induced DTH mouseSuppresses T cell-mediated inflammatory response [92]
PRMT5Inhibitor (HLCL65)MOG-induced EAE mouseSuppresses clinical signs of EAE through diminishing T cell-mediated inflammatory response [92]
PRMT5CD4+ T-cell specific KOMOG-induced EAE mouseSuppresses clinical signs of EAE through diminishing T cell-mediated inflammatory response [95]
PRMT6OverexpressionMN-1Exacerbates cytotoxicity due to polyglutamine-expanded AR [98]
DART8
(PRMT6 ortholog)
RNAi KDDrosophilaSuppresses neurodegenerative phenotype due to polyglutamine-expanded AR [98]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lee, J.; An, S.; Lee, S.-J.; Kang, J.-S. Correction: Lee et al. Protein Arginine Methyltransferases in Neuromuscular Function and Diseases. Cells 2022, 11, 364. Cells 2022, 11, 2609. https://0-doi-org.brum.beds.ac.uk/10.3390/cells11162609

AMA Style

Lee J, An S, Lee S-J, Kang J-S. Correction: Lee et al. Protein Arginine Methyltransferases in Neuromuscular Function and Diseases. Cells 2022, 11, 364. Cells. 2022; 11(16):2609. https://0-doi-org.brum.beds.ac.uk/10.3390/cells11162609

Chicago/Turabian Style

Lee, Jinwoo, Subin An, Sang-Jin Lee, and Jong-Sun Kang. 2022. "Correction: Lee et al. Protein Arginine Methyltransferases in Neuromuscular Function and Diseases. Cells 2022, 11, 364" Cells 11, no. 16: 2609. https://0-doi-org.brum.beds.ac.uk/10.3390/cells11162609

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop